Dyne Therapeutics Inc (DYN) — Cash Flow Reinvestment Rate

Latest as of December 2017: 2.73x

Dyne Therapeutics Inc (DYN) has a Cash Flow Reinvestment Rate of 2.73x as of December 2017, reinvesting $229.00 Million (capex $224.00 Million plus investments $5.00 Million) from operating cash flow of $84.00 Million. See Dyne Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

2.73x
(Capex + Investments) / Operating CF

Total Reinvested

$229.00 Million
Capex + Investments

Operating Cash Flow

$84.00 Million
USD

Capital Expenditures

$224.00 Million
USD

Dyne Therapeutics Inc Cash Flow Reinvestment Rate (2007–2017)

Historical reinvestment intensity for Dyne Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see Dyne Therapeutics Inc cash conversion from operations.

Annual Cash Flow Reinvestment Rate for Dyne Therapeutics Inc (2007–2017)

Year-by-year capital reinvestment analysis for Dyne Therapeutics Inc. See how financially flexible is Dyne Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2017 0.38x $224.00 Million $585.00 Million $224.00 Million ▼ -20.6%
2016 0.48x $326.00 Million $676.00 Million $326.00 Million ▼ -83.5%
2015 2.93x $275.00 Million $94.00 Million $275.00 Million ▲ +422.4%
2013 0.56x $98.00 Million $175.00 Million $98.00 Million ▼ -28.9%
2010 0.79x $333.00 Million $423.00 Million $333.00 Million
2009 0.00x $0.00 $135.00 Million $0.00
2008 0.00x $0.00 $319.00 Million $0.00
2007 0.00x $0.00 $341.00 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow